Emerging opportunities in the viral vector manufacturing market include personalized medicine growth, expanded clinical trials, and regional manufacturing partnerships. Advances in bioprocessing and ...

Cell and gene therapy outfit Oxford Biomedica said on Tuesday that it had agreed to acquire a viral vector manufacturing site ...

France's Institut Pasteur will keep its three COVID-19 vaccine projects running despite recent reports of high efficacy rates in two experimental shots by Moderna and Pfizer -BioNTech , , its science ...

OXB acquires Resilience’s site in North Carolina, an FDA-approved, commercial-scale viral vector manufacturing facility In line with OXB’s ...

IB [email protected] ReiThera to Showcase Innovative Viral Vector Platforms at ESGCT 2025Rome, Italy – September 30 2025 – ReiThera Srl, the Italian leading Contract Development ...

VectorBuilder, a global leader in the gene delivery space, has won two prestigious awards at the Asia-Pacific Cell and Gene ...

Cell culture media specialized for gene therapy production are uniquely designed to support the growth, viability, and productivity of cells used to manufacture gene therapy products, such as viral ...

First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...

Asimov has introduced a new manufacturing platform aimed at improving the scalability and consistency of AAV production for gene therapies.

Every day, human bone marrow produces around 200 billion new red blood cells. 1 But in five to seven out of every million people, that system is severely disrupted. 2 The result is Diamond-Blackfan ...

VintaBio announced it has filed provisional patents with the U.S. Patent and Trademark Office for a new approach to manufacturing biotherapeutics using adherent culturing methods in small-scale ...